Search Results - "Madriwala, Burhanuddin"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation by Gackowski, Marcin, Madriwala, Burhanuddin, Studzińska, Renata, Koba, Marcin

    Published in Molecules (Basel, Switzerland) (24-06-2023)
    “…Direct oral anticoagulants are an important and relatively new class of synthetic anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic…”
    Get full text
    Journal Article
  2. 2

    In silico design, docking simulation, and ANN-QSAR model for predicting the anticoagulant activity of thiourea isosteviol compounds as FXa inhibitors by Gackowski, Marcin, Madriwala, Burhanuddin, Koba, Marcin

    Published in Chemical papers (01-11-2023)
    “…Novel oral anticoagulants are frequently used for the pharmacotherapy of thromboembolic disorders but still have drawbacks and side effects. While numerous…”
    Get full text
    Journal Article
  3. 3

    Novel Thiourea and Oxime Ether Isosteviol-Based Anticoagulants: MD Simulation and ADMET Prediction by Gackowski, Marcin, Jędrzejewski, Mateusz, Medicharla, Sri Satya, Kondabala, Rajesh, Madriwala, Burhanuddin, Mądra-Gackowska, Katarzyna, Studzińska, Renata

    Published in Pharmaceuticals (Basel, Switzerland) (28-01-2024)
    “…Activated blood coagulation factor X (FXa) plays a critical initiation step of the blood-coagulation pathway and is considered a desirable target for…”
    Get full text
    Journal Article
  4. 4

    MOLECULAR DOCKING AND COMPUTATIONAL PHARMACOKINETIC STUDY OF SOME NOVEL COUMARIN–BENZOTHIAZOLE SCHIFF’S BASE FOR ANTIMICROBIAL ACTIVITY by MADRIWALA, BURHANUDDIN, JAYS, JUDY, SAI, G. CHAITANYA

    “…Objective: The present study discusses molecular docking of some novel coumarin–benzothiazole Schiff bases and the prediction of pharmacokinetic properties of…”
    Get full text
    Journal Article